Content about Medicinal chemistry

January 28, 2013

Health care is evolving. As obvious of a statement as that is, it doesn’t change the fact that it is very real. Throughout last year, there was intense discussion on the Patient Protection and Affordable Care Act and what impact the outcome of the presidential election might have on its future. Now that the Supreme Court has ruled and elections are settled, healthcare companies and providers across the country are implementing strategies to meet ACA requirements.

Health care is evolving. As obvious of a statement as that is, it doesn’t change the fact that it is very real. Throughout last year, there was intense discussion on the Patient Protection and Affordable Care Act and what impact the outcome of the presidential election might have on its future. Now that the Supreme Court has ruled and elections are settled, healthcare companies and providers across the country are implementing strategies to meet ACA requirements.

January 23, 2013

A lobbying organization for independent pharmacies has launched an ad campaign in The Hill, the Washington-based daily newspaper covering Congress.

ALEXANDRIA, Va. — A lobbying organization for independent pharmacies has launched an ad campaign in The Hill, the Washington-based daily newspaper covering Congress.

The National Community Pharmacists Association ad lays out the group's legislative agenda for the 113th Congress and the Obama administration.

January 23, 2013

A new study indicated that some parents may not be sufficiently concerned about misuse of narcotic painkillers by children and teenagers.

ANN ARBOR, Mich. — A new study indicated that some parents may not be sufficiently concerned about misuse of narcotic painkillers by children and teenagers.

January 15, 2013

H. D. Smith announced plans to secure majority ownership in Triplefin, a privately held reimbursement, patient assistance and pharmaceutical brand support services company headquartered in Cincinnati, Ohio.

SPRINGFIELD, Ill. — H. D. Smith on Tuesday announced plans to secure majority ownership in Triplefin, a privately held reimbursement, patient assistance and pharmaceutical brand support services company headquartered in Cincinnati, Ohio. H. D. Smith will immediately obtain majority board vote, and by mid-2013, majority stock ownership.

January 11, 2013

A panel of Food and Drug Administration experts has recommended approval for an experimental Type 2 diabetes drug made by Johnson & Johnson, the drug maker said.

RARITAN, N.J. -- A panel of Food and Drug Administration experts has recommended approval for an experimental Type 2 diabetes drug made by Johnson & Johnson, the drug maker said.

J&J said the FDA's Endocrinologic and Metabolic Drugs Advisory Committee had recommended approval for canagliflozin, which the company plans to market under the name brand Invokana. The FDA is not required to follow the votes of advisory committees when deciding whether or not to approve a drug, but usually does.

January 8, 2013

Biotech companies saw a decline in project delays due to regulations over the past year, as more than half have said insurance coverage and reimbursement issues have become more difficult, according to a new report.

SAN FRANCISCO — Biotech companies saw a decline in project delays due to regulations over the past year, as more than half have said insurance coverage and reimbursement issues have become more difficult, according to a new report.

The 2013 California Biomedical Industry Report — by PwC, the California Healthcare Institute and BayBio — looked at California's biotech industry and how it faired in 2012.

January 8, 2013

The Food and Drug Administration on Tuesday advised consumers not to purchase or use “MAXILOSS Weight Advanced” — a product promoted and sold for weight loss on various web sites, including DreamLifeWeightLoss.com, and in some retail stores.

SILVER SPRING, Md. — The Food and Drug Administration on Tuesday advised consumers not to purchase or use “MAXILOSS Weight Advanced” — a product promoted and sold for weight loss on various web sites, including DreamLifeWeightLoss.com, and in some retail stores.

January 7, 2013

More than half of U.S. consumers would not recommend a particular pharmacy to family and friends, according to a new report by a Canadian customer experience management firm.

TORONTO — More than half of U.S. consumers would not recommend a particular pharmacy to family and friends, according to a new report by a Canadian customer experience management firm.

January 2, 2013

In 2012, the Food and Drug Administration approved 39 new drugs, 8 alone in December, marking the largest increase in 16 years.

NEW YORK — In 2012, the Food and Drug Administration approved 39 new drugs, 8 alone in December, marking the largest increase in 16 years. The wave of approvals poises pharmaceutical makers to see big gains after billions in losses in recent years to generic drug makers because of patent expirations.

December 27, 2012

The Food and Drug Administration on Monday approved Aegerion Pharmaceuticals' cholesterol drug, Juxtapid.

CAMBRIDGE, Mass. — The Food and Drug Administration on Monday approved Aegerion Pharmaceuticals' cholesterol drug, Juxtapid.

The drug — an alternative treatment for patients who have a genetic predisposition to high cholesterol — will carry a boxed warning, the strongest level of FDA warning. Juxtapid will be available only through a restricted program due to risk of liver damage.

December 17, 2012

What pharmacy lobbying groups and Drug Store News have been saying for a while has reached the mainstream.

NEW YORK — What pharmacy lobbying groups and Drug Store News have been saying for a while has reached the mainstream.

The New York Times published an editorial over the weekend recommending that the country address its shortage of primary care doctors by relying more on other healthcare actors — such as pharmacists, nurse practitioners and patients themselves — as well as physician assistants and members of the community.

December 11, 2012

E-prescribing offers many well-known benefits to physicians, pharmacists and patients alike. Beyond the well-known patient benefits, real-time transactions with automated requests and responses promise to create efficiencies by speeding the medication ordering process, reducing or eliminating the back-and-forth communications between pharmacists and clinicians commonly associated with handwritten prescriptions.

E-prescribing offers many well-known benefits to physicians, pharmacists and patients alike. Beyond the well-known patient benefits, real-time transactions with automated requests and responses promise to create efficiencies by speeding the medication ordering process, reducing or eliminating the back-and-forth communications between pharmacists and clinicians commonly associated with handwritten prescriptions.

December 5, 2012

A network of pharmacies formed with the goal of helping patients achieve better health outcomes while reducing costs has appointed a new executive to its leadership team.

LEESBURG, Va. — A network of pharmacies formed with the goal of helping patients achieve better health outcomes while reducing costs has appointed a new executive to its leadership team.

RxAlly announced the appointment of Rebecca Chater as VP health outcomes. Chater, a pharmacist who has worked in clinical services for 20 years, will be responsible for providing leadership and clinical management of RxAlly solutions and integrating business development with clinical staff and operations.

December 3, 2012

Medical professionals continue to rank among the most-trusted officials, according to the latest annual Gallup survey around popular perception of professional honesty and ethics, particularly pharmacists.

ALEXANDRIA, Va. — Medical professionals continue to rank among the most-trusted officials, according to the latest annual Gallup survey around popular perception of professional honesty and ethics, particularly pharmacists.  

November 30, 2012

A new report shows that drug makers lose nearly $200 billion per year from medication nonadherence, illustrating that it's not just the healthcare system overall that loses when people don't take their medications properly.

This just goes to show the important role that pharmacy retailers have in helping to promote medication adherence by having pharmacists play an active role in patients' health care through services like medication therapy management.

A new report shows that drug makers lose nearly $200 billion per year from medication nonadherence, illustrating that it's not just the healthcare system overall that loses when people don't take their medications properly.

November 29, 2012

A Food and Drug Administration panel has voted to recommend approval for a Johnson & Johnson drug to treat tuberculosis while the agency has recommended accelerated approval for the drug, the company said.

RARITAN, N.J. — A Food and Drug Administration panel has voted to recommend approval for a Johnson & Johnson drug to treat tuberculosis while the agency has recommended accelerated approval for the drug, the company said.

November 29, 2012

Ultimately, there’s no “retail pharmacy” without the “pharmacy,” and that’s true of any store that dispenses prescription drugs — whether it’s a small independent drug store, a nationwide chain, a supermarket or a mass merchandiser. But in many respects, Rite Aid is trying to make the “pharmacy” component of that phrase just a little bit bigger.


Ultimately, there’s no “retail pharmacy” without the “pharmacy,” and that’s true of any store that dispenses prescription drugs — whether it’s a small independent drug store, a nationwide chain, a supermarket or a mass merchandiser. But in many respects, Rite Aid is trying to make the “pharmacy” component of that phrase just a little bit bigger.


November 29, 2012

For decades, community pharmacy has waged a tireless campaign to gain recognition as an equal partner on the nation’s healthcare delivery team, and support for the role pharmacists can play as front-line patient care advocates.

For decades, community pharmacy has waged a tireless campaign to gain recognition as an equal partner on the nation’s healthcare delivery team, and support for the role pharmacists can play as front-line patient care advocates. That campaign has become increasingly urgent as hospital and primary care costs go through the roof, payers seek lower-cost healthcare solutions and health reform shifts the focus from traditional modes of fee-for-service payment to a reimbursement system that rewards successful patient outcomes.


November 28, 2012

Some legislators are concerned with the way energy drinks can affect young consumers.

Some legislators are concerned with the way energy drinks can affect young consumers, especially in light of news reports linking several deaths with energy drink use.

Sens. Dick Durbin, D-Ill., and Richard Blumenthal, D-Conn., are urging the Food and Drug Administration to move quickly to review the safety of these drinks.

November 21, 2012

During Fred's third-quarter earnings call, the company told analysts it was testing a new, smaller format drug-dollar store concept and that its partnership with Diplomat was creating new clinical capabilities for the chain, which still sees pharmacy as a major growth opportunity.

The more Memphis-area patients continue singing those Delta blues, the more they're going to be scuffling through Fred's doors in their blue suede shoes. Effectively serving that economically-challenged patient is just one reason why Fred's third-quarter call this week should resonate across the industry. Because Fred's is in pursuit of two trends that are critical to its future — a specialty pharmacy solution that gains Fred's entree into the only growth-game in pharmacy, and an answer to its big-box competitors with a small-footprint, dollar-store/pharmacy hybrid.

November 12, 2012

Drug maker Purdue Pharma and the National Community Pharmacists Association have introduced the latest version of a video designed to educate pharmacists and other pharmacy staff about pharmacy crime.

STAMFORD, Conn. — Drug maker Purdue Pharma and the National Community Pharmacists Association have introduced the latest version of a video designed to educate pharmacists and other pharmacy staff about pharmacy crime.

The video, part of RxPatrol, Purdue's broader initiative to combat pharmacy crime, launched on the initiative's website. Titled "RxPatrol Pharmacy Safety and Security," it is free of charge, and is part of the NCPA's Protect Your Pharmacy Now! initiative, which started in 2008.

November 7, 2012

The Food and Drug Administration on Monday issued a warning letter to The Avalon Effect, a company based in Franklin, Tenn., for its marketing of a light therapy product that claims to cure or treat symptoms of fungal meningitis, methicillin-resistant Staphylococcus aureus, concussions, Lyme disease and other diseases.

SILVER SPRING, Md. — The Food and Drug Administration on Monday issued a warning letter to The Avalon Effect, a company based in Franklin, Tenn., for its marketing of a light therapy product that claims to cure or treat symptoms of fungal meningitis, methicillin-resistant Staphylococcus aureus, concussions, Lyme disease and other diseases.

November 7, 2012

Americans woke up Wednesday morning to the news that Barack Obama had won a second term as president of the United States. DSN examines what it means for retail pharmacy.

NEW YORK — Americans woke up Wednesday morning to the news that Barack Obama had won a second term as president of the United States. Some people may be happy about that, others unhappy and others neutral — but win or lose, the results of Tuesday's election affect everyone, including those in the retail pharmacy industry.

November 5, 2012

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating internal blood clots, the company said.

RARITAN, N.J. — The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating internal blood clots, the company said.

J&J subsidiary Janssen Pharmaceuticals announced the approval of Xarelto (rivaroxaban) for treating deep-vein thrombosis and pulmonary embolism and to reduce the risk of recurrence of the clotting conditions after initial treatment.

The company said Xarelto was the first oral anticoagulant approved to treat DVT and PE without the need for injections or routine blood-monitoring.

November 5, 2012

Rx Response, an initiative of America’s bio-pharmaceutical supply system to help ensure the continued flow of medicine to patients in a severe public health emergency, has continued its close coordination with federal, state and local government agencies to address impacts from Hurricane Sandy on the bio-pharmaceutical supply system, the organization announced Friday.

WASHINGTON — Rx Response, an initiative of America’s bio-pharmaceutical supply system to help ensure the continued flow of medicine to patients in a severe public health emergency, has continued its close coordination with federal, state and local government agencies to address impacts from Hurricane Sandy on the bio-pharmaceutical supply system, the organization announced Friday.